Mary Ann Huang, MD
Gastroenterology · Denver, CONPI 1477621902
Payments from drug & device makers
Across 609 payments — averaging $669.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$138K
- Gilead$103K
- Intercept Pharmaceuticals, Inc.$65K
- Madrigal Pharmaceuticals$59K
- Bayer$21K
- Dova Pharmaceuticals$7K
- plus $14K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 233 | $137,708 |
| Gilead | 133 | $103,480 |
| Intercept Pharmaceuticals, Inc. | 79 | $65,276 |
| Madrigal Pharmaceuticals | 60 | $58,919 |
| Bayer | 26 | $21,009 |
| Dova Pharmaceuticals | 9 | $7,221 |
| Ipsen Biopharmaceuticals, Inc | 13 | $6,597 |
| Shionogi Inc | 11 | $5,984 |
| Sanofi | 7 | $259 |
| Fujifilm Healthcare Americas Corporation | 1 | $199 |
| Exact Sciences | 2 | $193 |
| Medtronic | 3 | $181 |
| Novo Nordisk | 5 | $176 |
| Intuitive Surgical | 1 | $91 |
| Orphalan Inc | 2 | $62 |
| Braintree Laboratories, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| AstraZeneca | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $47 |
| Johnson & Johnson | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 2 | $31 |
| Bristol Myers Squibb | 2 | $29 |
| Merck | 1 | $20 |
| Veloxis Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| QOL Medical, LLC | 1 | $13 |
| ERBE USA Inc | 1 | $12 |
How this compares
$407,827 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Denver
- Pranav PeriyalwarDenver$180K
- Jonathon FishmanDenver$92K
- Stephen NewDenver$16K
- Joseph ChangDenver$10K
- Bhaktasharan PatelColorado Springs$22M
- Marcelo KugelmasEnglewood$2.7M
- Douglas AdlerColorado Springs$1.2M
- Masi KhajaGrand Junction$1.2M
- Peter McNallyFt Carson$1.1M
- Mark GerichAurora$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.